China Pharma (NYSE:CPHI) Research Coverage Started at StockNews.com

StockNews.com started coverage on shares of China Pharma (NYSE:CPHI) in a research report released on Friday morning. The firm issued a hold rating on the stock.

China Pharma Stock Down 7.1 %

CPHI stock opened at $0.24 on Friday. China Pharma has a 12 month low of $0.13 and a 12 month high of $0.44. The company has a debt-to-equity ratio of 0.22, a current ratio of 0.79 and a quick ratio of 0.26. The firm has a 50 day simple moving average of $0.22 and a 200 day simple moving average of $0.22.

About China Pharma

China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People’s Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.